Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes

Mikhail Kosiborod, Mark Colquhoun Petrie, Barry A. Borlaug, Javed Butler, Melanie Jane Davies, G. Kees Hovingh, Dalane W. Kitzman, Daniél V. Møller, Marianne Bach Treppendahl, Subodh Verma, Thomas Jensen, Karoline Liisberg, Marie L.S. Lindegaard, Walter P. Abhayaratna, Fozia Zahir Ahmed, Tuvia Ben Gal, Vijay Chopra, Justin Adrian Ezekowitz, Michael L.X. Fu, Hiroshi Ito, Małgorzata Lelonek, Vojtěch Melenovský, Béla Péter Merkely, Julio E. Núñez, Eduardo Roque Perna, and 7 more

View at source ↗Article753 citations
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.

Record

Archive ID
doi:10.1056/nejmoa2313917
Published
Mar 28, 2024
Venue
New England Journal of Medicine
DOI
10.1056/nejmoa2313917
PubMed
38587233
Categories
Heart Failure Treatment and Management
License
other-oa
Provenance
openalex

Topics

Cited in dossiers